Works by Huang, Jee‐Fu


Results: 125
    1
    2
    3

    Therapy as prevention toward HCV elimination in maintenance hemodialysis: a multi-center, prospective cohort study.

    Published in:
    Clinical Kidney Journal, 2023, v. 16, n. 12, p. 2429, doi. 10.1093/ckj/sfad138
    By:
    • Huang, Chung-Feng;
    • Dai, Chia-Yen;
    • Wang, Chih-Wen;
    • Liang, Po-Cheng;
    • Wei, Yu-Ju;
    • Tsai, Pei-Chien;
    • Jang, Tyng-Yuan;
    • Hsu, Po-Yao;
    • Lee, Jia-Jung;
    • Niu, Sheng-Wen;
    • Huang, Jiun-Chi;
    • Yeh, Ming-Lun;
    • Huang, Ching-I;
    • Hsieh, Ming-Yen;
    • Lin, Yi-Hung;
    • Chen, Szu-Chia;
    • Chiu, Yi-Wen;
    • Huang, Jee-Fu;
    • Chang, Jer-Ming;
    • Hwang, Shang-Jyh
    Publication type:
    Article
    4
    5
    6
    7
    8

    Viral Interference Between Dengue Virus and Hepatitis C Virus Infections.

    Published in:
    Open Forum Infectious Diseases, 2020, v. 7, n. 8, p. 1, doi. 10.1093/ofid/ofaa272
    By:
    • Liang, Po-Cheng;
    • Chen, Kuan-Yu;
    • Huang, Chung-Hao;
    • Chang, Ko;
    • Lu, Po-Liang;
    • Yeh, Ming-Lun;
    • Huang, Chung-Feng;
    • Huang, Ching-I;
    • Hsieh, Meng-Hsuan;
    • Dai, Chia-Yen;
    • Lin, Zu-Yau;
    • Chen, Shinn-Chern;
    • Chuang, Wan-Long;
    • Chen, Yen-Hsu;
    • Huang, Jee-Fu;
    • Yu, Ming-Lung
    Publication type:
    Article
    9
    10

    Nationwide registry of glecaprevir plus pibrentasvir in the treatment of HCV in Taiwan.

    Published in:
    Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-03006-3
    By:
    • Huang, Chung-Feng;
    • Kuo, Hsing-Tao;
    • Chang, Te-Sheng;
    • Lo, Ching-Chu;
    • Hung, Chao-Hung;
    • Huang, Chien-Wei;
    • Chong, Lee-Won;
    • Cheng, Pin-Nan;
    • Yeh, Ming-Lun;
    • Peng, Cheng-Yuan;
    • Cheng, Chien-Yu;
    • Huang, Jee-Fu;
    • Bair, Ming-Jong;
    • Lin, Chih-Lang;
    • Yang, Chi-Chieh;
    • Wang, Szu-Jen;
    • Hsieh, Tsai-Yuan;
    • Lee, Tzong-Hsi;
    • Lee, Pei-Lun;
    • Wu, Wen-Chih
    Publication type:
    Article
    11

    Air Pollution Associated With Mortality Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2025, v. 61, n. 9, p. 1458, doi. 10.1111/apt.70019
    By:
    • Jang, Tyng‐Yuan;
    • Zeng, Yu‐Ting;
    • Liang, Po‐Cheng;
    • Wu, Chih‐Da;
    • Wei, Yu‐Ju;
    • Tsai, Pei‐Chien;
    • Hsieh, Ming‐Yen;
    • Lin, Yi‐Hung;
    • Hsieh, Meng‐Hsuan;
    • Wang, Chih‐Wen;
    • Yang, Jeng‐Fu;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Chuang, Wan‐Long;
    • Huang, Jee‐Fu;
    • Cheng, Ya‐Yun;
    • Dai, Chia‐Yen;
    • Chen, Pau‐Chung;
    • Yu, Ming‐Lung
    Publication type:
    Article
    12
    13
    14

    Editorial: increasing burden of nonalcoholic fatty liver disease—a call to action. Authors' reply.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 12, p. 1430, doi. 10.1111/apt.15718
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon‐Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L.‐H.;
    • Wong, Vincent W.‐S.;
    • Razavi, Homie
    Publication type:
    Article
    15

    Modelling NAFLD disease burden in four Asian regions—2019‐2030.

    Published in:
    Alimentary Pharmacology & Therapeutics, 2020, v. 51, n. 8, p. 801, doi. 10.1111/apt.15673
    By:
    • Estes, Chris;
    • Chan, Henry L. Y.;
    • Chien, Rong N.;
    • Chuang, Wan‐Long;
    • Fung, James;
    • Goh, George Boon-Bee;
    • Hu, Tsung H.;
    • Huang, Jee‐Fu;
    • Jang, Byoung K.;
    • Jun, Dae W.;
    • Kao, Jia H.;
    • Lee, Jin‐Woo;
    • Lin, Han‐Chieh;
    • Razavi‐Shearer, Kathryn;
    • Seto, Wai‐Kay;
    • Wong, Grace L. ‐H.;
    • Wong, Vincent W. ‐S.;
    • Razavi, Homie
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30

    The tertiary prevention of hepatocellular carcinoma in chronic hepatitis C patients.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 12, p. 1768, doi. 10.1111/jgh.13012
    By:
    • Huang, Jee‐Fu;
    • Yeh, Ming‐Lun;
    • Yu, Ming‐Lung;
    • Dai, Chia‐Yen;
    • Huang, Chung‐Feng;
    • Huang, Ching‐I;
    • Tsai, Pei‐Chien;
    • Lin, Pei‐Chen;
    • Chen, Yao‐Li;
    • Chang, Wen‐Tsan;
    • Hou, Nai‐Jen;
    • Lin, Zu‐Yau;
    • Chen, Shinn‐Cherng;
    • Chuang, Wan‐Long
    Publication type:
    Article
    31

    Chronic hepatitis C infection is associated with insulin resistance and lipid profiles.

    Published in:
    Journal of Gastroenterology & Hepatology, 2015, v. 30, n. 5, p. 879, doi. 10.1111/jgh.12313
    By:
    • Dai, Chia‐Yen;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Hou, Chen‐Hsiu;
    • Hsieh, Ming‐Yen;
    • Huang, Jee‐Fu;
    • Lin, I‐Ling;
    • Lin, Zu‐Yau;
    • Chen, Shinn‐Chern;
    • Wang, Liang‐Yen;
    • Chuang, Wan‐Long;
    • Yu, Ming‐Lung;
    • Tung, Hung‐Da
    Publication type:
    Article
    32
    33

    Clinical utility of host genetic IL-28 B variants in hepatitis C virus genotype 1 Asian patients retreated with pegylated interferon plus ribavirin.

    Published in:
    Journal of Gastroenterology & Hepatology, 2013, v. 28, n. 9, p. 1515, doi. 10.1111/jgh.12211
    By:
    • Huang, Chung‐Feng;
    • Yeh, Ming‐Lun;
    • Hsieh, Meng‐Hsuan;
    • Hsieh, Ming‐Yen;
    • Lin, Zu‐Yau;
    • Chen, Shinn‐Cherng;
    • Wang, Liang‐Yen;
    • Huang, Jee‐Fu;
    • Juo, Suh‐Hang Hank;
    • Lin, Yi‐Ching;
    • Dai, Chia‐Yen;
    • Chuang, Wan‐Long;
    • Yu, Ming‐Lung
    Publication type:
    Article
    34

    Incidence and clinical outcome of icteric type hepatocellular carcinoma.

    Published in:
    Journal of Gastroenterology & Hepatology, 2002, v. 17, n. 2, p. 190, doi. 10.1046/j.1440-1746.2002.02677.x
    By:
    • HUANG, JEE-FU;
    • WANG, LIANG-YEN;
    • LIN, ZU-YAU;
    • CHEN, SHINN-CHERN;
    • HSIEH, MING-YUH;
    • CHUANG, WAN-LONG;
    • YU, MING-LUNG;
    • LU, SHENG-NAN;
    • WANG, JING-HOUNG;
    • YEUNG, KWOK-WAN;
    • CHANG, WEN-YU
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41

    Benefits of Hepatitis C Viral Eradication: A Real-World Nationwide Cohort Study in Taiwan.

    Published in:
    Digestive Diseases & Sciences, 2024, v. 69, n. 9, p. 3501, doi. 10.1007/s10620-024-08512-8
    By:
    • Chang, Chin-Wei;
    • Hsu, Wei-Fan;
    • Tseng, Kuo-Chih;
    • Chen, Chi-Yi;
    • Cheng, Pin-Nan;
    • Hung, Chao-Hung;
    • Lo, Ching-Chu;
    • Bair, Ming-Jong;
    • Chen, Chien-Hung;
    • Lee, Pei-Lun;
    • Lin, Chun-Yen;
    • Kuo, Hsing-Tao;
    • Chen, Chun-Ting;
    • Yang, Chi-Chieh;
    • Huang, Jee-Fu;
    • Tai, Chi-Ming;
    • Hu, Jui-Ting;
    • Lin, Chih-Lang;
    • Su, Wei-Wen;
    • Tsai, Wei-Lun
    Publication type:
    Article
    42
    43

    Role of Air Pollution in Development of Hepatocellular Carcinoma Among Chronic Hepatitis B Patients Treated With Nucleotide/Nucleoside Analogues.

    Published in:
    Liver International, 2025, v. 45, n. 4, p. 1, doi. 10.1111/liv.16149
    By:
    • Jang, Tyng‐Yuan;
    • Zeng, Yu‐ting;
    • Liang, Po‐Cheng;
    • Wu, Chih‐Da;
    • Wei, Yu‐Ju;
    • Tsai, Pei‐Chien;
    • Hsu, Po‐Yao;
    • Hsieh, Ming‐Yen;
    • Lin, Yi‐Hung;
    • Hsieh, Meng‐Hsuan;
    • Wang, Chih‐Wen;
    • Yang, Jeng‐Fu;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Chuang, Wan‐Long;
    • Huang, Jee‐Fu;
    • Cheng, Ya‐Yun;
    • Dai, Chia‐Yen;
    • Chen, Pau‐Chung;
    • Yu, Ming‐Lung
    Publication type:
    Article
    44
    45

    Factors associated with treatment failure of direct‐acting antivirals for chronic hepatitis C: A real‐world nationwide hepatitis C virus registry programme in Taiwan.

    Published in:
    Liver International, 2021, v. 41, n. 6, p. 1265, doi. 10.1111/liv.14849
    By:
    • Chen, Chi‐Yi;
    • Huang, Chung‐Feng;
    • Cheng, Pin‐Nan;
    • Tseng, Kuo‐Chih;
    • Lo, Ching‐Chu;
    • Kuo, Hsing‐Tao;
    • Huang, Yi‐Hsiang;
    • Tai, Chi‐Ming;
    • Peng, Cheng‐Yuan;
    • Bair, Ming‐Jong;
    • Chen, Chien‐Hung;
    • Yeh, Ming‐Lun;
    • Lin, Chih‐Lang;
    • Lin, Chun‐Yen;
    • Lee, Pei‐Lun;
    • Chong, Lee‐Won;
    • Hung, Chao‐Hung;
    • Huang, Jee‐Fu;
    • Yang, Chi‐Chieh;
    • Hu, Jui‐Ting
    Publication type:
    Article
    46

    Exosome‐derived differentiation antagonizing non‐protein coding RNA with risk of hepatitis C virus‐related hepatocellular carcinoma recurrence.

    Published in:
    Liver International, 2021, v. 41, n. 5, p. 956, doi. 10.1111/liv.14772
    By:
    • Wang, Shu‐Chi;
    • Li, Chia‐Yang;
    • Chang, Wen‐Tsan;
    • Cheng, Wei‐Chung;
    • Yen, Chia‐Hung;
    • Tu, Wen‐Yu;
    • Lin, Zu‐Yau;
    • Lin, Ching‐Chih;
    • Yeh, Ming‐Lun;
    • Huang, Chung‐Feng;
    • Huang, Jee‐Fu;
    • Dai, Chia‐Yen;
    • Chuang, Wan‐Long;
    • Chen, Yao‐Li;
    • Yu, Ming‐Lung
    Publication type:
    Article
    47
    48
    49
    50